NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that the first subject has been enrolled and ...
Three people with a muscle-destroying disease destined to worsen got a little stronger -- able to stand and walk more easily -- when an implanted device zapped their spinal cord.